We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
5 Things You Need to Know About Epilepsy & Depression
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
W. Brian Gibler, MD, FACEP, FACC, FAHA
Adrian R. Parry-Jones, FRCP, PhD
Stuart Connolly, MD, FRCPC
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Rhonda Cadena, MD, FNCS, FCCM
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
Greg Albers, MD
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
Natalie Kreitzer, MD, MS
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
Patient-Centric Approaches to Managing Migraines in the Female Patient
Jessica Ailani, MD
Dawn C. Buse, PhD
How Should We Monitor Patients on Amyloid-Targeting Therapy?
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Which Amyloid-Targeting Therapy is Best?
The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy
Is Amyloid-Targeting Therapy Worth It?
What’s the Best Way to Identify Mild Cognitive Impairment and Early Alzheimer’s Disease?
What Does ARIA Look Like Clinically?
Which Biomarkers Do You Recommend to Confirm Amyloid Positivity?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education